Secondary household transmission of SARS-CoV-2: a case-control study on factors associated with reduced transmission risk.

COVID-19 History of SARS-CoV-2 infection Home isolation Household transmission Omicron-targeting vaccine

Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 02 05 2023
revised: 24 09 2023
accepted: 24 09 2023
medline: 4 12 2023
pubmed: 4 10 2023
entrez: 3 10 2023
Statut: ppublish

Résumé

This study aimed to identify factors deterring secondary household transmission of SARS-CoV-2 from SARS-CoV-2-positive cohabitants. A case-control study was conducted with 272 healthcare workers in close contact with SARS-CoV-2-positive cohabitants. Logistic regression modeling was employed to determine the factors independently associated with secondary household transmission. A SARS-CoV-2 infection within the past 6 months was the most protective factor against secondary household transmission (adjusted odds ratio = 0.07, 95% CI: 0.01-0.61, P <0.05). Home isolation and older age of primary index case (7-12, ≥18 years) were also associated with a reduced risk. Both monovalent and bivalent messenger ribonucleic acid booster vaccinations exhibited potential protective tendencies but were not statistically significant. Additionally, bivalent vaccines did not demonstrate a clear advantage over monovalent vaccines. A recent history of SARS-CoV-2 infection, home isolation of positive cohabitants, and older age of primary index cases were positively associated with a reduced risk of secondary household transmission. Regarding booster vaccinations, data from a single center with a limited sample size may not capture all statistically significant differences, necessitating broader studies.

Identifiants

pubmed: 37788740
pii: S1201-9712(23)00733-6
doi: 10.1016/j.ijid.2023.09.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4-8

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of competing interest The authors have no competing interests to declare.

Auteurs

Masato Inaba (M)

Division of Infectious Diseases, Central Japan International Medical Center, Mino-Kamo, Gifu, Japan. Electronic address: masato11011979@gmail.com.

Yukiko Miyake (Y)

Division of Infection Control and Prevention, Central Japan International Medical Center, Mino-Kamo, Gifu, Japan.

Kazutaka Yasuda (K)

Department of Hospital Pharmacy, Central Japan International Medical Center, Mino-Kamo, Gifu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH